BIA
Barry Investment Advisors’s GSK GSK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $744K | Sell |
19,203
-1,232
| -6% | -$47.8K | 0.19% | 55 |
|
|
2025
Q1 | $800K | Sell |
20,435
-26
| -0.1% | -$1.02K | 0.21% | 52 |
|
|
2024
Q4 | $692K | Buy |
20,461
+1,741
| +9% | +$58.9K | 0.22% | 56 |
|
|
2024
Q3 | $765K | Buy |
18,720
+687
| +4% | +$28.1K | 0.23% | 53 |
|
|
2024
Q2 | $694K | Sell |
18,033
-21
| -0.1% | -$808 | 0.23% | 56 |
|
|
2024
Q1 | $774K | Sell |
18,054
-2,591
| -13% | -$111K | 0.26% | 50 |
|
|
2023
Q4 | $772K | Sell |
20,645
-1,263
| -6% | -$47.3K | 0.26% | 50 |
|
|
2023
Q3 | $801K | Buy |
21,908
+2,188
| +11% | +$80K | 0.29% | 52 |
|
|
2023
Q2 | $710K | Sell |
19,720
-731
| -4% | -$26.3K | 0.24% | 62 |
|
|
2023
Q1 | $735K | Buy |
20,451
+2,872
| +16% | +$103K | 0.24% | 62 |
|
|
2022
Q4 | $618K | Buy |
17,579
+3,960
| +29% | +$139K | 0.2% | 69 |
|
|
2022
Q3 | $406K | Buy |
+13,619
| New | +$406K | 0.14% | 79 |
|
|
2022
Q2 | – | Sell |
-15,818
| Closed | -$699K | – | 125 |
|
|
2022
Q1 | $699K | Buy |
15,818
+38
| +0.2% | +$1.68K | 0.19% | 68 |
|
|
2021
Q4 | $696K | Buy |
15,780
+34
| +0.2% | +$1.5K | 0.18% | 63 |
|
|
2021
Q3 | $610K | Buy |
15,746
+107
| +0.7% | +$4.15K | 0.17% | 66 |
|
|
2021
Q2 | $629K | Buy |
15,639
+292
| +2% | +$11.7K | 0.17% | 66 |
|
|
2021
Q1 | $554K | Buy |
15,347
+2,630
| +21% | +$94.9K | 0.15% | 68 |
|
|
2020
Q4 | $473K | Buy |
12,717
+6,598
| +108% | +$245K | 0.14% | 66 |
|
|
2020
Q3 | $232K | Buy |
+6,119
| New | +$232K | 0.08% | 76 |
|